Assoc. Prof. Dr. Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member
Istanbul University-Cerrahpasa Cardiology Institute | Turkey
Umit YaĆar Sinan is an accomplished cardiovascular specialist whose career reflects sustained academic excellence, broad clinical expertise, and meaningful contributions to contemporary cardiology. After completing rigorous medical and cardiology training at leading institutions, he advanced rapidly through academic ranks and currently serves as an Associate Professor of Cardiology, where he is recognized for his dedication to research, teaching, and advanced patient care. His international experience includes focused work in adult congenital heart disease and pulmonary hypertension at a major UK referral center, strengthening his profile in complex cardiac conditions. Over the years, he has cultivated deep clinical interests spanning echocardiography, invasive cardiology, structural heart disease, pulmonary hypertension, adult congenital heart disease, heart failure, and atherosclerosis. His scholarly productivity is reflected in 90 scientific documents, which have collectively received 559 citations from 531 sources, supporting an h-index of 14 an indicator of his growing influence in cardiovascular research. He remains actively engaged in professional communities, holding memberships and leadership roles across prominent international and national cardiology societies, where he contributes to collaborative initiatives in acute cardiovascular care, imaging, valvular heart disease, congenital heart disease, and pulmonary vascular disorders. Through this blend of academic leadership, clinical depth, and research impact, he continues to shape advancements in cardiology both within his institution and across the broader scientific community.
Featured Publications
Yaylalı, Y. T., YaÄmur, B., Sinan, Ă. Y., Meriç, M., BaĆarıcı, İ., Kılıçkıran Avcı, B., Ćenol, H., Nalbantgil, S., KĂŒĂ§ĂŒkoÄlu, S., & Ăngen, Z. (2023). Risk assessment tool implementation in congenital heart disease-associated pulmonary arterial hypertension. Anatolian Journal of Cardiology, 27(8), 479-485.
KocabaĆ, U., Ergin, İ., Kıvrak, T., Yılmaz Ăztekin, G. M., Tanık, V. O., Ăzdemir, İ., Avcı Demir, F., DoÄduĆ, M., Ćen, T., Altınsoy, M., ĂstĂŒndaÄ, S., Urgun, Ă. D., Sinan, Ă. Y., Uygur, B., Yeni, M., & Ăzçalık, E. (2023). Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 10(6), 3677-3689.
Akyıldız Akçay, F., Sinan, Ă. Y., GĂŒrbĂŒz, D. Ă., Ćafak, Ă., Kaya, H., YĂŒksek, Ă., & Zoghi, M. (2023). Gender-related differences in patients with acute heart failure: Observation from the Journey Heart Failure-Turkish Population Study. Anatolian Journal of Cardiology, 27(11), 639-649.
Sinan, U. Y., Serin, E., Keskin-Meriç, B., & Arat-Ozkan, A. (2023). Cre8 drug eluting stent performance in daily cardiology practice. IMR Press, 24(2), 53.
ĆabanoÄlu, C., Sinan, Ă. Y., AkboÄa, M. K., Ăoner, A., Gök, G., KocabaĆ, U., Bekar, L., Gazi, E., Cengiz, M., Kılıç, S., İnanç, İ. H., Ăakmak, H. A., & Zoghi, M. (2023). Long-term prognosis of patients with heart failure: Follow-up results of Journey HF-TR study population. Anatolian Journal of Cardiology, 27(1), 26-33.